Semaglutide, the active ingredient in diabetes medications Ozempic and Wegovy, was associated with a significantly reduced ...

Beyond helping diabetes patients lose weight and control blood sugar, semaglutide appears to cut dementia risk by nearly half ...

Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications ...

A new experimental treatment may be able to cure type 1 diabetes. About 83% of the patients were able to stop using insulin ...

Canadian study reveals diabetic patients taking GLP-1 medications face twice the risk of eye problems, with longer exposure ...

Diabetes pills could hit Australian shelves within years, offering an alternative to popular injectable treatments such as ...

A massive U.S. study found diabetics on semaglutide (Ozempic’s active ingredient) had up to 70% lower risk of ...

A new study involving nearly 1.7 million patients suggests that semaglutide — a drug that mimics a gut hormone to lower blood sugar and aid weight loss — could significantly cut dementia risk in older ...

Combining physician education with patient previsit activation increases deprescribing of diabetes medications, according to one study.

Controlling weight and cardiovascular risk factors is paramount in type 2 diabetes management; however, the definition and ...